RACHAEL BIRGE: Open Payments
NPI 1851960702 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,282 in 66 payments from 13 companies in 2025. Trend: 2023 $1,778 · 2024 $402 · 2025 $1,282
Food & beverage: $1,259Education: $23
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 12 | $216 |
| Axsome Therapeutics, Inc. | 10 | $200 |
| Supernus Pharmaceuticals, Inc. | 8 | $185 |
| Collegium Pharmaceutical, Inc. | 10 | $149 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $80 |
| Janssen Pharmaceuticals, Inc | 3 | $78 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $69 |
| Lundbeck LLC | 3 | $66 |
| ABBVIE INC. | 3 | $60 |
| Biogen, Inc. | 2 | $55 |
Products named: REXULTI, Auvelity, Qelbree, Jornay PM, CAPLYTA, SPRAVATO, TRINTELLIX, VRAYLAR.
Industry payments across IN — which companies pay providers there.
